Palvella Therapeutics (PVLA) Earnings Date & Reports

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PVLA is expected to report earnings to rise 17.76% to -178 cents per share on November 17

Palvella Therapeutics PVLA Stock Earnings Reports

Q3'26

Est.

$-1.79

Q2'26

Missed

by $0.36

Q1'26

Missed

by $0.71

Q4'25

Beat

by $0.04

Q3'25

Beat

by $1.10

The last earnings report on August 04 showed earnings per share of -151 cents, missing the estimate of -115 cents. With 92.61K shares outstanding, the current market capitalization sits at 1.99B.

View a ticker or compare two or three

PVLA

Daily Signal:

Gain/Loss:

Biotechnologies - Trading Results
AI Trading Agent, 60min Biotechnologies - Trading Results
AI Trading Agent, 60min

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement